enkephalin, d-penicillamine (2,5)- and diazoxide

enkephalin, d-penicillamine (2,5)- has been researched along with diazoxide in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lohmann, AB; Welch, SP	2

Other Studies

2 other study(ies) available for enkephalin, d-penicillamine (2,5)- and diazoxide

Article	Year
ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides. European journal of pharmacology, 1999, Dec-03, Volume: 385, Issue:2-3 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adenosine Triphosphate; Analgesics; Animals; Cromakalim; Diazoxide; Dose-Response Relationship, Drug; Drug Interactions; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine; Glyburide; Injections, Intraventricular; Ion Channel Gating; Male; Mice; Mice, Inbred ICR; Morphine; Naltrexone; Narcotic Antagonists; Nociceptors; Opioid Peptides; Pain; Potassium Channels; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Somatostatin	1999
Antisenses to opioid receptors attenuate ATP-gated K(+) channel opener-induced antinociception. European journal of pharmacology, 1999, Nov-19, Volume: 384, Issue:2-3 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adenosine Triphosphate; Analgesia; Analgesics; Animals; Cromakalim; Diazoxide; Enkephalin, D-Penicillamine (2,5)-; Male; Mice; Mice, Inbred ICR; Morphine; Nociceptors; Oligodeoxyribonucleotides, Antisense; Pain; Potassium Channels; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu	1999

Article

Year

ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.

European journal of pharmacology, 1999, Dec-03, Volume: 385, Issue:2-3

Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adenosine Triphosphate; Analgesics; Animals; Cromakalim; Diazoxide; Dose-Response Relationship, Drug; Drug Interactions; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine; Glyburide; Injections, Intraventricular; Ion Channel Gating; Male; Mice; Mice, Inbred ICR; Morphine; Naltrexone; Narcotic Antagonists; Nociceptors; Opioid Peptides; Pain; Potassium Channels; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Somatostatin

1999

Antisenses to opioid receptors attenuate ATP-gated K(+) channel opener-induced antinociception.

European journal of pharmacology, 1999, Nov-19, Volume: 384, Issue:2-3

Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adenosine Triphosphate; Analgesia; Analgesics; Animals; Cromakalim; Diazoxide; Enkephalin, D-Penicillamine (2,5)-; Male; Mice; Mice, Inbred ICR; Morphine; Nociceptors; Oligodeoxyribonucleotides, Antisense; Pain; Potassium Channels; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu

1999